carbamates and Disease Models, Animal studies

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

Excerpt	Relevance	Reference
" Doxapram is an analeptic capable of inducing panic attacks with respiratory symptoms in individuals diagnosed with the disorder; however, its neuroanatomical targets and its effects on experimental animals remain uncharacterized."	8.02	Intravenous doxapram administration as a potential model of panic attacks in rats. ( Batista, LA; Brianis, RC; Haibara, AS; Lopes, JB; Moreira, FA, 2021)
"To determine the effects of retigabine and flupirtine on pain behavior associated with monosodium urate (MSU)-induced gout arthritis."	7.96	Antinociceptive Efficacy of Retigabine and Flupirtine for Gout Arthritis Pain. ( Huo, B; Jin, L; Li, H; Liu, R; Liu, S; Tang, L; Wang, Y; Yang, T; Zhang, F; Zhao, X, 2020)
"Hypoxia caused activation of calpains as measured by accumulation of the calpain-specific 145 kDa α-spectrin breakdown product."	7.80	Calpain protease causes hypoxia-induced proteolysis in cultured human retina. ( Azuma, M; Hammond, KB; Nakajima, E; Shearer, TR, 2014)
"Increased vascular sensitivity to angiotensin II (Ang II) is a marker of a hypertensive human pregnancy."	7.80	Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis. ( Bader, M; Brosnihan, KB; Dechend, R; Howlett, AC; McGee, CM; Pulgar, VM; Varagic, J; Yamaleyeva, LM, 2014)
"Administration of carisbamate during status epilepticus (SE) prevents the occurrence of motor seizures in the lithium-pilocarpine model and leads in a subpopulation of rats to spike-and-wave discharges characteristic of absence epilepsy."	7.79	A comprehensive behavioral evaluation in the lithium-pilocarpine model in rats: effects of carisbamate administration during status epilepticus. ( Akimana, G; Carneiro, JE; Cassel, JC; Cosquer, B; Faure, JB; Ferrandon, A; Geiger, K; Koning, E; Nehlig, A; Penazzi, L, 2013)
"To test the efficiency of locally administrated tresperimus in experimental autoimmune uveoretinitis (EAU)."	7.77	Protective effect of intravitreal administration of tresperimus, an immunosuppressive drug, on experimental autoimmune uveoretinitis. ( Annat, J; Behar-Cohen, F; Besson-Lescure, B; Bousquet, E; Camelo, S; de Kozak, Y; Goldenberg, B; Lebreton, L; Leroux les Jardins, G; Naud, MC, 2011)
" Oxotremorine is a cholinergic agonist known to induce acute hypothermia."	7.74	Oxotremorine-induced hypothermia as a method for evaluating long-term neuronal changes following poisoning by cholinesterase inhibitors in rats. ( Grauer, E; Levy, A, 2007)
"Our results suggested that orally available calpain inhibitor SNJ-1945 might be a possible candidate drug for testing in preventing progression of glaucomatous retinal degeneration."	7.73	Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester. ( Azuma, M; Nakajima, E; Oka, T; Shearer, TR; Tamada, Y; Tochigi, A; Walkup, RD, 2006)
"Diazepam-resistant SE was induced in adult mice fed with standard or ketogenic diet or in cannabinoid receptor type 1 (CB1) receptor knock-out mice."	5.48	Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet. ( Butler, CR; Guilmette, E; Pauletti, A; Piro, JR; Porcu, L; Rizzi, M; Salamone, A; Samad, TA; Sheehan, MJ; Terrone, G; Vezzani, A; Villa, BR, 2018)
"Local injection of OMDM-1 reduced hyperalgesia in vivo in mice with unilateral tumors in and around the calcaneous bone."	5.39	Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain. ( Burlakova, N; Coicou, L; Harding-Rose, C; Holman, M; Khasabova, IA; Morse, T; Seybold, VS; Simone, DA, 2013)
" Doxapram is an analeptic capable of inducing panic attacks with respiratory symptoms in individuals diagnosed with the disorder; however, its neuroanatomical targets and its effects on experimental animals remain uncharacterized."	4.02	Intravenous doxapram administration as a potential model of panic attacks in rats. ( Batista, LA; Brianis, RC; Haibara, AS; Lopes, JB; Moreira, FA, 2021)
"This study was designed to determine the involvement of the endocannabinoid system in anxiety- and depression-related behaviors in methamphetamine-withdrawal male NMRI mice."	4.02	URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels. ( Ebrahimi-Ghiri, M; Khakpai, F; Zarrindast, MR, 2021)
"To determine the effects of retigabine and flupirtine on pain behavior associated with monosodium urate (MSU)-induced gout arthritis."	3.96	Antinociceptive Efficacy of Retigabine and Flupirtine for Gout Arthritis Pain. ( Huo, B; Jin, L; Li, H; Liu, R; Liu, S; Tang, L; Wang, Y; Yang, T; Zhang, F; Zhao, X, 2020)
" Here, we have studied the effects of the selective MAGL inhibitors JZL184 and MJN110 and their underlying molecular mechanisms on 3 different experimental models of focal cerebral ischemia."	3.88	Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke. ( Arai, AL; Choi, SH; Hallenbeck, J; Kang, B; Mou, Y; Silva, AC; Yen, CC, 2018)
"JZL195 and the cannabinoid receptor agonist WIN55212 produced dose-dependent reductions in CCI-induced mechanical and cold allodynia, plus side effects including motor incoordination, catalepsy and sedation."	3.83	Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model. ( Adamson Barnes, NS; Kazantzis, NP; Mitchell, VA; Vaughan, CW, 2016)
" administration of morphine and the selective MAGL inhibitor 2,5-dioxopyrrolidin-1-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate (MJN110) were tested alone and in combination at equieffective doses for reversal of CCI-induced mechanical allodynia and thermal hyperalgesia."	3.83	The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model. ( Abdullah, RA; Akbarali, H; Banks, ML; Cravatt, BF; Dewey, WL; Grim, TW; Lichtman, AH; Mustafa, MA; Niphakis, MJ; Poklis, JL; Wilkerson, JL; Wise, LE, 2016)
"The pharmacological inhibition of anandamide (AEA) hydrolysis by fatty acid amide hydrolase (FAAH) attenuates pain in animal models of osteoarthritis (OA) but has failed in clinical trials."	3.81	A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis. ( Binkowski, M; Czaja, M; Di Marzo, V; Kolosowska, N; Makuch, W; Malek, N; Morera, E; Mrugala, M; Przewlocka, B; Starowicz, K, 2015)
"Sodium Salicylate (SS) reliably induces a sensorineural hearing loss and tinnitus when administered in high doses."	3.81	Potassium ion channel openers, Maxipost and Retigabine, protect against peripheral salicylate ototoxicity in rats. ( Chen, GD; Salvi, R; Sheppard, AM, 2015)
"We evaluated the effectiveness of the potent selective monoacylglycerol lipase (MAGL) inhibitor, MJN110, which selectively elevates the endocannabinoid 2-AG, to suppress acute nausea and vomiting, as well as anticipatory nausea in rat and shrew models."	3.81	Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus. ( Abdullah, RA; Cravatt, BF; Downey, R; Lichtman, AH; Limebeer, CL; Morris, H; Niphakis, MJ; Parker, LA; Rock, EM; Sticht, MA, 2015)
" We show that calcium gluconate supplementation can increase bone mineral density in gastrectomized individuals and performs superior to calcium carbonate in restoring calcium/skeletal homoeostasis in a mouse model of achlorhydria."	3.81	Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy. ( Amling, M; Barvencik, F; Beil, B; Keller, J; Krause, M; Schinke, T; van Driel, I; Zustin, J, 2015)
" Two distinct FAAH inhibitory compounds, URB597 and PF-3845 were tested, and contrasted with standard antinociceptive gabapentin or vehicle treatment, for attenuation of tactile allodynia, cold allodynia, and mechanical hyperalgesia."	3.81	Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy. ( Jergova, S; Nasirinezhad, F; Pearson, JP; Sagen, J, 2015)
"Hypoxia caused activation of calpains as measured by accumulation of the calpain-specific 145 kDa α-spectrin breakdown product."	3.80	Calpain protease causes hypoxia-induced proteolysis in cultured human retina. ( Azuma, M; Hammond, KB; Nakajima, E; Shearer, TR, 2014)
"Thirty-five Sprague-Dawley rats were subjected to lithium-pilocarpine status epilepticus."	3.80	Attention and executive functions in a rat model of chronic epilepsy. ( Akimana, G; Barbelivien, A; Cassel, JC; Cosquer, B; Faure, JB; Ferrandon, A; Herbeaux, K; Koning, E; Marques-Carneiro, JE; Nehlig, A, 2014)
"Increased vascular sensitivity to angiotensin II (Ang II) is a marker of a hypertensive human pregnancy."	3.80	Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis. ( Bader, M; Brosnihan, KB; Dechend, R; Howlett, AC; McGee, CM; Pulgar, VM; Varagic, J; Yamaleyeva, LM, 2014)
"Administration of carisbamate during status epilepticus (SE) prevents the occurrence of motor seizures in the lithium-pilocarpine model and leads in a subpopulation of rats to spike-and-wave discharges characteristic of absence epilepsy."	3.79	A comprehensive behavioral evaluation in the lithium-pilocarpine model in rats: effects of carisbamate administration during status epilepticus. ( Akimana, G; Carneiro, JE; Cassel, JC; Cosquer, B; Faure, JB; Ferrandon, A; Geiger, K; Koning, E; Nehlig, A; Penazzi, L, 2013)
" Using a conditional transgenic mouse model, selective ablation of adult neural stem and progenitor cells in the subventricular zone induced a dramatic increase in morbidity and mortality of central nervous system disorders characterized by excitotoxicity-induced cell death accompanied by reactive inflammation, such as 4-aminopyridine-induced epilepsy and ischaemic stroke."	3.78	Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity. ( Bacigaluppi, M; Bari, M; Brambilla, E; Butti, E; Cambiaghi, M; Cebrian Silla, A; Centonze, D; Comi, G; D'Adamo, P; De Ceglia, R; De Chiara, V; Garcia-Verdugo, JM; Leocani, L; Maccarrone, M; Martino, G; Musella, A; Muzio, L; Quattrini, A; Rossi, S; Teneud, L, 2012)
" In all models, URB937 was as effective or more effective than standard analgesic and anti-inflammatory drugs (indomethacin, gabapentin, dexamethasone) and reversed pain-related responses (mechanical hyperalgesia, thermal hyperalgesia, and mechanical allodynia) in a dose-dependent manner."	3.78	Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions. ( Armirotti, A; Bandiera, T; Bertorelli, R; Colombano, G; Moreno-Sanz, G; Piomelli, D; Reggiani, A; Sasso, O; Scarpelli, R, 2012)
"To test the efficiency of locally administrated tresperimus in experimental autoimmune uveoretinitis (EAU)."	3.77	Protective effect of intravitreal administration of tresperimus, an immunosuppressive drug, on experimental autoimmune uveoretinitis. ( Annat, J; Behar-Cohen, F; Besson-Lescure, B; Bousquet, E; Camelo, S; de Kozak, Y; Goldenberg, B; Lebreton, L; Leroux les Jardins, G; Naud, MC, 2011)
" In the rat Li-pilocarpine status epilepticus model, CYM2503, injected intraperitoneally, increased the latency to first electrographic seizure and the latency to first stage 3 behavioral seizure, decreased the latency to the establishment of status epilepticus, and dramatically decreased the mortality."	3.76	GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. ( Baldwin, R; Bartfai, T; Chang, J; Liu, T; Lu, X; Roberts, E; Sanchez-Alavez, M; Wasterlain, CG; Wu, S; Xia, F, 2010)
"The role of K(ATP) channels in the antiarrhythmic effect of Escherichia coli endotoxin-induced nitric oxide synthase (iNOS) was examined in an anesthetised rat model of myocardial ischemia and reperfusion arrhythmia by using glibenclamide (1 mg kg(-1)), nateglinide (10 mg kg(-1)) and repaglinide (0."	3.74	Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels. ( Erkent, U; Ertunc, M; Guc, MO; Ilhan, M; Iskit, AB; Onur, R, 2007)
" Carisbamate reduced the frequency of spontaneous motor seizures in a dose-dependent manner, and was more effective than topiramate at reducing seizures in rats with kainate-induced epilepsy."	3.74	A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy. ( Dudek, FE; Grabenstatter, HL, 2008)
"3 mg kg(-1), intraperitoneal [IP]) for 5 weeks corrected the reduction in body weight gain and sucrose intake induced by CMS."	3.74	Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. ( Arguello, O; Bortolato, M; Duranti, A; Fu, J; Kim, JH; Mangieri, RA; Mor, M; Piomelli, D; Tarzia, G; Tontini, A, 2007)
" The results show that the bis-2,2,2-trichloroethyl carbamates function effectively in a rat model for Pneumocystis pneumonia."	3.74	Carbamate prodrugs of N-alkylfuramidines. ( Boykin, DW; Hall, JE; Jones, SK; Rahmathullah, SM; Tidwell, RR, 2008)
" Oxotremorine is a cholinergic agonist known to induce acute hypothermia."	3.74	Oxotremorine-induced hypothermia as a method for evaluating long-term neuronal changes following poisoning by cholinesterase inhibitors in rats. ( Grauer, E; Levy, A, 2007)
"Our results suggested that orally available calpain inhibitor SNJ-1945 might be a possible candidate drug for testing in preventing progression of glaucomatous retinal degeneration."	3.73	Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester. ( Azuma, M; Nakajima, E; Oka, T; Shearer, TR; Tamada, Y; Tochigi, A; Walkup, RD, 2006)
"The utility of Chinese hamsters as a test species for aneuploidy analysis was studied using four chemicals--vincristine, methyl 2-benzimidazole carbamate (MBC), nocodazole, and cyclophosphamide."	3.68	The feasibility of using Chinese hamsters as an animal model for aneuploidy. ( Arras, CA; Jones, RL; Lavappa, KS; Lee, JK; Sheu, CW, 1990)
"In human volunteers, studies to assess the adverse effects of the carbamate anticholinesterase physostigmine showed that the intramuscular dose observed to induce emesis in 50% of subjects tested (ED50) was 28."	3.68	A model for carbamate and organophosphate-induced emesis in humans. ( D'Mello, GD; Sidell, FR, 1991)
" Consequently, the aim of the current study was to comparatively evaluate the pharmacokinetic (PK) and pharmacodynamic (PD anticonvulsant activity) profile of EMC and IPC individual enantiomers."	2.79	Enantioselective pharmacodynamic and pharmacokinetic analysis of two chiral CNS-active carbamate derivatives of valproic acid. ( Bialer, M; Finnell, RH; Mawasi, H; McDonough, JH; Shekh-Ahmad, T; Wlodarczyk, BJ; Yavin, E, 2014)
"Indoxam was found to suppress the elevation of the plasma level of TNF-alpha and prolonged the survival of endotoxin-challenged mice."	2.41	[Functional analysis of phospholipase A2 receptor by gene knockout studies]. ( Yokota, Y, 2001)
"The cholinergic hypofunction in Alzheimer's disease (AD) appears to be linked with two other major hallmarks of this disease, beta-amyloid and hyperphosphorylated tau protein."	2.41	Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists. ( Fisher, A, 2000)
"The decreased hyperalgesia was associated with a reduction in CGRP and cytokine gene expression levels in central and peripheral structures and reduced CGRP serum levels."	1.62	Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine. ( Demartini, C; Francavilla, M; Greco, R; Tassorelli, C; Zanaboni, AM, 2021)
"Givinostat treatment increased maximal normalized strength to levels that were comparable to those of healthy mice in both DMD models."	1.62	The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene. ( Crippa, L; Fossati, G; Leoni, F; Licandro, SA; Perego, R; Pomarico, R; Steinkühler, C, 2021)
"Similar to clinical PTSD, approximately 25-30% of rats that undergo cued fear conditioning exhibit impaired extinction learning."	1.56	Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder. ( Diwan, M; Giacobbe, P; Gidyk, DC; Gouveia, FV; Hamani, C; Lipsman, N; Nobrega, JN; Vimalanathan, A, 2020)
" Chronic administration of the compound did not appear to affect tumor burden, as evidenced by radiograph or histologic analysis."	1.56	The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain. ( BassiriRad, N; Ciccone, HA; Cravatt, BF; Grenald, SA; Largent-Milnes, TM; Niphakis, MJ; Thompson, AL; Vanderah, TW, 2020)
" We developed a long-acting DAA system (LA-DAAS) capable of prolonged dosing and explored its cost-effectiveness."	1.56	Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine. ( Chu, JN; Collins, J; Eweje, F; Faiz, MT; Gwynne, D; Hayward, A; Hess, K; Hua, T; Ishida, K; Katz, S; Koeppen, R; Langer, R; Lopes, A; McManus, R; Miller, JB; Salama, JAF; Slocum, AH; Soares, V; Steiger, C; Sulkowski, MS; Tamang, SM; Thomas, DL; Traverso, G; Verma, M, 2020)
" The present study tested whether chronic administration of the fatty acid amide hydrolase (FAAH) inhibitor [3-(3-carbamoylphenyl) phenyl]N-cyclohexylcarbamate (URB597) to rats with primary hypertension (SHR) can modify redox balance and consequently brain phospholipid metabolism."	1.56	The FAAH Inhibitor URB597 Modulates Lipid Mediators in the Brain of Rats with Spontaneous Hypertension. ( Baranowska-Kuczko, M; Biernacki, M; Niklińska, GN; Skrzydlewska, E, 2020)
"Neuropathic pain is often associated with depression."	1.51	Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain. ( Gong, DY; Hai, KR; Jiang, HX; Ke, BW; Liu, J; Ma, G; Yang, Z; Zhou, C, 2019)
" The aim of this study was to compare the effect of chronic administration of URB597, the FAAH (fatty acid amide hydrolase) inhibitor, to rats with primary (SHRs) and secondary (DOCA-salt hypertensive rats) hypertension on electrical and physicochemical properties of kidney cells membranes."	1.51	Changes in physicochemical properties of kidney cells membrane as a consequence of hypertension and treatment of hypertensive rats with FAAH inhibitor. ( Dobrzyńska, I; Figaszewski, ZA; Skrzydlewska, E; Szachowicz-Petelska, B; Weresa, J, 2019)
"Givinostat treatment mediated an accelerated wound closure in scratch assays."	1.51	HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation. ( Friedrich, M; Gerbeth, L; Gerling, M; Glauben, R; Keye, J; Rosenthal, R; Schmidt, F; Siegmund, B; Steiger, K; Weichert, W; Weidinger, C; Wu, H, 2019)
"Diazepam-resistant SE was induced in adult mice fed with standard or ketogenic diet or in cannabinoid receptor type 1 (CB1) receptor knock-out mice."	1.48	Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet. ( Butler, CR; Guilmette, E; Pauletti, A; Piro, JR; Porcu, L; Rizzi, M; Salamone, A; Samad, TA; Sheehan, MJ; Terrone, G; Vezzani, A; Villa, BR, 2018)
"influenced gastric motility, elicited catalepsy, or hypothermia."	1.48	Modulation of central endocannabinoid system results in gastric mucosal protection in the rat. ( Fehér, Á; Gyertyán, I; Gyires, K; Németh, J; Tóth, VE; Zádori, ZS, 2018)
"Posttraumatic stress disorder (PTSD) is a debilitating condition highly comorbid with depression."	1.48	Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD. ( Akirav, I; Burstein, O; Doron, R; Shoshan, N, 2018)
"Increased neuronal excitability causes seizures with debilitating symptoms."	1.48	egl-4 modulates electroconvulsive seizure duration in C. elegans. ( Dawson-Scully, K; Jia, K; Kelly, SP; Minnerly, J; Risley, MG, 2018)
"It was suggested that in PTSD, hippocampal-dependent memory is compromised while amygdala-dependent memory is strengthened."	1.46	Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity. ( Abush, H; Akirav, I; Mizrachi Zer-Aviv, T; Segev, A; Shoshan, N, 2017)
"Chronic pain and hyperalgesia, as well as pain resulting from episodes of vaso-occlusion, are characteristic features of sickle cell disease (SCD) and are difficult to treat."	1.46	Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis. ( Gupta, K; Simone, DA; Uhelski, ML, 2017)
" In the R6/2 mouse HD model, induced DREAM haplodeficiency or blockade of DREAM activity by chronic administration of the drug repaglinide delayed onset of motor dysfunction, reduced striatal atrophy, and prolonged life span."	1.43	Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease. ( Arrabal, MD; Casado-Vela, J; Cercós, P; De la Cruz, A; Dopazo, XM; González, P; González, T; Gutierrez-Rodriguez, M; Higueras, E; Li, JY; Mellström, B; Morón-Oset, J; Naranjo, JR; Oliveros, JC; Prieto, A; Rábano, A; Valenzuela, C; Villar, D; Zhang, H, 2016)
" Whether repeated dosing would achieve greater protection remains to be examined."	1.42	Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury. ( Impastato, RA; Katz, PS; Molina, PE; Rogers, EK; Sulzer, JK; Teng, SX, 2015)
"Remarkably, the long-lasting widespread hyperalgesia induced by combining CUS and NGF was effectively reduced by URB597, but not by JZL184."	1.42	Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. ( Bindila, L; Hoheisel, U; Lerner, R; Lomazzo, E; Lutz, B; Remmers, F; Schwitter, C, 2015)
"Orofacial cold hyperalgesia was induced in rats either by the administration of oxaliplatin or by infraorbital nerve chronic constrictive injury."	1.42	KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia. ( Abd-Elsayed, AA; Gu, JG; Ikeda, R; Jia, Z; Li, M; Ling, J; Zuo, X, 2015)
"We found that nitroglycerin-induced mechanical allodynia and neuronal activation of the trigeminal nucleus were completely abolished in FAAH-deficient mice."	1.42	Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice. ( Markert, A; Nozaki, C; Zimmer, A, 2015)
"Although inactive in acute seizure tests, repeated administration of SAR127303 delays the acquisition and decreases kindled seizures in mice, indicating that the drug slows down epileptogenesis, a finding deserving further investigation to evaluate the potential of MAGL inhibitors as antiepileptics."	1.42	Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents. ( Arlt, H; Augé, F; Avenet, P; Beeské, S; Bergis, OE; Bert, L; Bertrand, T; Brittain, S; Didier, M; Escoubet, J; Even, L; Françon, D; George, P; Griebel, G; He, T; Houtmann, J; Jacquet, A; Leroy, T; Lopez-Grancha, M; Menet, V; Michot, N; Mikol, V; Pichat, P; Rak, A; Redon, N; Sun, F; Tolstykh, T; Vallée, F; Wiederschain, D; Yu, Q; Zhang, B, 2015)
"Using a rat model of bone cancer pain based on intratibial injection of MRMT-1 tumor cells, we observed a significant increase in C-fiber responses of dorsal horn WDR neurons in the MRMT-1 injected rats, indicating sensitization of spinal WDR neurons in bone cancer rats."	1.42	Suppression of KCNQ/M (Kv7) potassium channels in the spinal cord contributes to the sensitization of dorsal horn WDR neurons and pain hypersensitivity in a rat model of bone cancer pain. ( Cai, J; Fang, D; Li, S; Liu, XD; Ren, J; Xing, GG, 2015)
"Schizophrenia is a debilitating disorder that affects 1% of the US population."	1.40	Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia. ( Aguilar, DD; Chen, L; Lodge, DJ, 2014)
"Cerebral vasospasm after subarachnoid hemorrhage (SAH) is characterized by prolonged severe constriction of the basilar artery, which often leads to ischemic brain damage."	1.39	Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm. ( Brueggemann, LI; Byron, KL; Kumar, L; Mani, BK; O'Dowd, J; Ross, M, 2013)
"Local injection of OMDM-1 reduced hyperalgesia in vivo in mice with unilateral tumors in and around the calcaneous bone."	1.39	Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain. ( Burlakova, N; Coicou, L; Harding-Rose, C; Holman, M; Khasabova, IA; Morse, T; Seybold, VS; Simone, DA, 2013)
"Effects of pre-treatment with a single dose, versus 4 day repeated dosing with the selective FAAH inhibitor, URB597 (i."	1.38	Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system. ( Alexander, SP; Barrett, DA; Bennett, AJ; Burston, J; Chapman, V; Kendall, DA; Norris, LM; Okine, BN; Patel, A; Woodhams, S, 2012)
" Cisplatin produces a cumulative toxic effect on peripheral nerves, and 30-40% of cancer patients receiving this agent experience pain."	1.38	Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy. ( Harding-Rose, C; Khasabov, S; Khasabova, IA; Paz, J; Seybold, VS; Simone, DA, 2012)
"At least, part of antiseizure effects of cannabinoid compounds is mediated through calcium (Ca(2+)) channels."	1.38	L-type calcium channel mediates anticonvulsant effect of cannabinoids in acute and chronic murine models of seizure. ( Ahmad-Molaei, L; Eslahkar, S; Mazar-Atabaki, A; Motiei-Langroudi, SM; Naderi, N; Ronaghi, A; Shirazi-zand, Z, 2012)
"flank injection of B16 melanoma cells."	1.38	The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action. ( Bouzin, C; Feron, O; Gallez, B; Hamtiaux, L; Lambert, DM; Masquelier, J; Muccioli, GG, 2012)
"Infantile spasms are the signature seizures of West syndrome."	1.37	Carisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasms. ( Galanopoulou, AS; Moshé, SL; Ono, T, 2011)
"Transgenic models of Alzheimer's disease (AD) have made significant contributions to our understanding of AD pathogenesis, and are useful tools in the development of potential therapeutics."	1.37	Characterization of a Drosophila Alzheimer's disease model: pharmacological rescue of cognitive defects. ( Ansaloni, S; Chakraborty, R; Delvadia, R; Desai, A; Goldstein, LE; Khandelwal, P; Lee, JC; Marenda, DR; Melicharek, DJ; Mhatre, SD; Michelson, SJ; Miller, S; Moir, RD; Paddock, BE; Saunders, AJ; Tabb, LP; Utreja, S; Vepuri, V; Vinokur, M, 2011)
"Only minor effects on seizure thresholds and seizure parameters without a clear dose-dependency were observed in fully kindled mice."	1.37	Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice. ( Potschka, H; Soerensen, J; Wendt, H; Wotjak, CT, 2011)
"05-10 μg/mouse) produced antidepressant-like effect dose-dependently, whereas influenced the MBB in a biphasic manner (produced a U-shaped dose-response curve)."	1.37	Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice. ( Jain, NS; Manna, SS; Umathe, SN, 2011)
"These findings demonstrate that AM966 is a potent, selective, orally bioavailable LPA(1) receptor antagonist that may be beneficial in treating lung injury and fibrosis, as well as other diseases that are characterized by pathological inflammation, oedema and fibrosis."	1.36	A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. ( Baccei, CS; Bundey, RA; Chapman, C; Correa, LD; Evans, JF; Fagan, P; Hutchinson, JH; Lorrain, DS; Parr, TA; Prasit, P; Prodanovich, PC; Santini, AM; Seiders, TJ; Stebbins, KJ; Swaney, JS, 2010)
"Pre-treatment with ethanolamine decreased infarct size in isolated mouse or rat hearts subjected to I/R but this infarct sparing effect was lost in cardiomyocyte specific STAT-3 deficient mice."	1.36	Ethanolamine is a novel STAT-3 dependent cardioprotective agent. ( Hacking, D; Kelly, RF; Lacerda, L; Lamont, KT; Lecour, S; Opie, LH; Somers, S; Thomas, P, 2010)
"Pretreatment with lamotrigine significantly attenuated AMPH/CDP-induced effects, but also reduced motility when tested in the presence of CDP-alone."	1.35	Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania. ( Nielsen, AN; Redrobe, JP, 2009)
"Repaglinide (RPG) is an oral hypoglycemic agent with excellent bioavailability (90-98%) and a short plasma half-life (2-6 h)."	1.35	Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus. ( Jain, S; Saraf, S, 2009)
"Inflammatory hyperalgesia was measured following intraplantar injection of carrageenan."	1.35	Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain. ( Alexander, SP; Barrett, DA; Bennett, AJ; Chapman, V; Garle, MJ; Jhaveri, MD; Kendall, DA; Patel, A; Richardson, D; Robinson, I; Sagar, DR; Sun, Y, 2008)
"Genomic DNA from 202 patients with Crohn's disease (CD) and 206 healthy controls was analyzed for the C385A polymorphism in the FAAH gene to address a possible role in humans."	1.35	Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors. ( Brand, S; Buckley, NE; Emmerdinger, D; Göke, B; Keenan, CM; Lutz, B; Massa, F; Patel, KD; Sharkey, KA; Sibaev, A; Storr, MA; Yüce, B; Zhang, H, 2008)
"Cholestasis is associated with increased activity of the endogenous opioid system that results in analgesia."	1.35	Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis. ( Hasanein, P; Komaki, A; Mirazi, N; Shahidi, S, 2008)
" The isobolographic analysis for parallel and nonparallel dose-response effects was used in the mouse maximal electroshock seizure (MES) model for evaluation of pharmacodynamic interaction."	1.35	Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model. ( Czuczwar, SJ; Luszczki, JJ; Raszewski, G; Wu, JZ, 2009)
"In models of Parkinson's disease, indirect-pathway eCB-LTD is absent but is rescued by a D2 receptor agonist or inhibitors of endocannabinoid degradation."	1.34	Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. ( Kreitzer, AC; Malenka, RC, 2007)
"In BFNC, seizures begin shortly after birth, and spontaneously remit in the first few months of life."	1.34	K+ M-current regulates the transition to seizures in immature and adult hippocampus. ( Johnson, BN; Qiu, C; Tallent, MK, 2007)
"We have used a model of focal cerebral ischemia in young adult mice to investigate the relationship between focal cerebral ischemia and endogenous NAEs."	1.34	Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice. ( Artmann, A; Clausen, BH; Degn, M; Finsen, B; Hansen, HS; Hansen, SH; Lambertsen, KL; Lund, TM; Meldgaard, M; Petersen, G, 2007)
"Paroxysmal dyskinesias with dystonia are a group of movement disorders which are regarded as ion channelopathies, but the role of Kv7 channels in the pathogenesis and as targets for the treatment have so far not been examined."	1.33	Antidystonic effects of Kv7 (KCNQ) channel openers in the dt sz mutant, an animal model of primary paroxysmal dystonia. ( Richter, A; Rundfeldt, C; Sander, SE, 2006)
" With the use of a double sucrose gap-recording chamber we perform a dose-response assay to examine the effects of these compounds on axonal conduction following an in vitro stretch injury."	1.33	Dose responses of three 4-aminopyridine derivatives on axonal conduction in spinal cord trauma. ( Borgens, RB; Byrn, SR; McBride, JM; Shi, R; Smith, DT, 2006)
" The compound was not toxic for cultured rat hepatic cells."	1.33	Antiamoebic and toxicity studies of a carbamic acid derivative and its therapeutic effect in a hamster model of hepatic amoebiasis. ( Angeles, E; Arriaga-Alba, M; de la Garza, M; Ordaz-Pichardo, C; Shibayama, M; Villa-Treviño, S, 2005)
"Szt1 mouse seizure thresholds were significantly reduced relative to B6 littermates in the minimal clonic, minimal tonic hindlimb extension, and partial psychomotor seizure models."	1.32	Mice carrying the szt1 mutation exhibit increased seizure susceptibility and altered sensitivity to compounds acting at the m-channel. ( Frankel, WN; Otto, JF; White, HS; Wilcox, KS; Yang, Y, 2004)
"Carbamazepine (100 mg/kg) was weakly effective against all the responses."	1.31	Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain. ( Field, MJ; Gonzalez, MI; Hughes, J; Singh, L, 2000)
"Like devazepide, IQM-95,333 was a more potent antagonist of CCK-8S- than of CCK-4-induced contraction of the longitudinal muscle from guinea-pig ileum, suggesting selective antagonism at CCKA receptors."	1.30	Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models. ( Ballaz, S; Barber, A; Del Río, J; Fortuño, A; García-López, MT; Gómez-Monterrey, I; González-Muñiz, R; Herranz, R; Martin-Martínez, M, 1997)
" Compounds from this class exhibit good cholesterol lowering in a chronic cholesterol-fed rat model of hypercholesterolemia even when dosed in an aqueous vehicle."	1.29	Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivo. ( Blankley, CJ; Hamelehle, KL; Krause, BR; O'Brien, PM; Roth, BD; Sliskovic, DR; Stanfield, RL; Wilson, MW, 1994)
" Chronic exposure to kartolin-2, and, specifically to its preparation form in the dose 1/100 LD50 cause lipid infiltration, reduction of histochemical indicators of liver glycogen, and RNA content."	1.28	[Morphological evaluation of toxic effect of kartolin-2]. ( Aĭvazian, LK, 1990)
"Rat nasal squamous cell carcinomas induced by inhalation of three direct-acting alkylating agents yielded DNA containing activated oncogenes with no homology to any member of the ras family."	1.27	Detection of novel non-ras oncogenes in rat nasal squamous cell carcinomas. ( Currie, DD; Felber, M; Garte, SJ; Hochwalt, AE; Wirgin, I, 1988)

Timeframe	Studies, this research(%)	All Research%
pre-1990	9 (3.66)	18.7374
1990's	10 (4.07)	18.2507
2000's	57 (23.17)	29.6817
2010's	141 (57.32)	24.3611
2020's	29 (11.79)	2.80

Trial	Phase	Enrollment	Study Type	Start Date	Status
Peripheral Gene Expression of Endocannabinoid System Components in Episodic and Chronic Migraine Patients: a Pilot Study[NCT04324710]		75 participants (Actual)	Observational	2017-12-12	Completed
Expression of Inflammasomes in HCV Patients Before and After Treatment[NCT04244383]	Phase 4	50 participants (Anticipated)	Interventional	2020-01-31	Not yet recruiting
Osteoarthritis of the Knee Pain Study Using CBD and THC in Rapidly Dissolvable Sublingual Tablet[NCT04195269]	Phase 2	30 participants (Anticipated)	Interventional	2020-04-20	Recruiting
Genetic, Epigenetic, Psychosocial, and Biological Determinants of Post-surgical Pain After Pectus or Spine Surgery[NCT04031716]		600 participants (Anticipated)	Interventional	2018-07-06	Enrolling by invitation
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Article	Year
What is the promise of new antiepileptic drugs in status epilepticus? Focus on brivaracetam, carisbamate, lacosamide, NS-1209, and topiramate. Epilepsia, 2009, Volume: 50 Suppl 12 Topics: Acetamides; Animals; Anticonvulsants; Carbamates; Disease Models, Animal; Fructose; Humans; Lacosami	2009
Retigabine for partial onset seizures. Expert review of neurotherapeutics, 2012, Volume: 12, Issue:5 Topics: Animals; Anticonvulsants; Carbamates; Disease Models, Animal; Epilepsies, Partial; Humans; Phenylene	2012
Novel medication targets for the treatment of alcoholism: preclinical studies. Recent patents on CNS drug discovery, 2012, Volume: 7, Issue:2 Topics: Alcohol Deterrents; Alcoholism; Animals; Azepines; Azetidines; Carbamates; Disease Models, Animal; D	2012
The clinical development of new mitotic inhibitors that stabilize the microtubule. Anti-cancer drugs, 2004, Volume: 15, Issue:6 Topics: Alkanes; Animals; Carbamates; Cell Line, Tumor; Clinical Trials, Phase I as Topic; Clinical Trials,	2004
[A new aspect in the research on antiepileptic drugs]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2007, Volume: 129, Issue:2 Topics: Acetamides; Amines; Animals; Anticonvulsants; Benzodiazepines; Carbamates; Cyclohexanecarboxylic Aci	2007
Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists. Japanese journal of pharmacology, 2000, Volume: 84, Issue:2 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Carbamates; Cheirogaleidae; Disease Mo	2000
[Functional analysis of phospholipase A2 receptor by gene knockout studies]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2001, Volume: 121, Issue:1 Topics: Animals; Carbamates; Disease Models, Animal; Enzyme Inhibitors; Group II Phospholipases A2; Group X	2001

carbamates and Disease Models, Animal

Research Excerpts

Research

Studies (246)

Authors

Clinical Trials (4)

Trial Overview

Reviews

Trials

Other Studies

Authors	Studies
Ebrahimi-Ghiri, M	2
Shahini, F	1
Zarrindast, MR	2
Greco, R	2
Demartini, C	2
Francavilla, M	1
Zanaboni, AM	2
Tassorelli, C	2
Viel, C	2
Clarke, J	2
Kayatekin, C	1
Richards, AM	2
Chiang, MSR	1
Park, H	4
Wang, B	5
Shihabuddin, LS	2
Sardi, SP	2
da Motta, KP	1
Santos, BF	1
Domingues, NLC	1
Luchese, C	1
Wilhelm, EA	1
Selvaraj, P	1
Tanaka, M	2
Wen, J	1
Zhang, Y	5
Lei, H	1
Li, Z	1
Li, T	1
Wu, H	2
Yang, J	1
Yang, X	2
Yang, Y	2
Jiang, N	1
Zhai, X	1
Wu, HF	1
Lu, TY	1
Chu, MC	1
Chen, PS	1
Lee, CW	1
Lin, HC	1
Zeng, Z	1
Wang, L	2
Ma, W	1
Zheng, R	1
Zhang, H	5
Zeng, X	1
Zhang, W	1
Hoffmann, M	1
Stiller, C	1
Endres, E	1
Scheiner, M	1
Gunesch, S	1
Sotriffer, C	1
Maurice, T	1
Decker, M	1
Maymon, N	1
Mizrachi Zer-Aviv, T	2
Sabban, EL	2
Akirav, I	5
Tumelero, E	1
Reggiani, A	2
Misto, A	1
Piomelli, D	6
Dong, B	1
Shilpa, BM	1
Shah, R	1
Goyal, A	1
Xie, S	2
Bakalian, MJ	1
Suckow, RF	1
Cooper, TB	2
Mann, JJ	1
Arango, V	1
Vinod, KY	2
Su, SH	2
Wu, YF	2
Lin, Q	4
Wang, DP	2
Hai, J	4
Vimalanathan, A	1
Gidyk, DC	1
Diwan, M	1
Gouveia, FV	1
Lipsman, N	1
Giacobbe, P	1
Nobrega, JN	1
Hamani, C	1
Dobrzyńska, I	2
Szachowicz-Petelska, B	2
Pędzińska-Betiuk, A	3
Figaszewski, ZA	2
Skrzydlewska, E	4
Thompson, AL	1
Grenald, SA	1
Ciccone, HA	1
BassiriRad, N	1
Niphakis, MJ	4
Cravatt, BF	5
Largent-Milnes, TM	1
Vanderah, TW	1
Zhang, F	1
Liu, S	1
Jin, L	1
Tang, L	1
Zhao, X	1
Yang, T	1
Wang, Y	1
Huo, B	1
Liu, R	1
Li, H	2
Verma, M	1
Chu, JN	1
Salama, JAF	1
Faiz, MT	1
Eweje, F	1
Gwynne, D	1
Lopes, A	1
Hess, K	1
Soares, V	1
Steiger, C	1
McManus, R	1
Koeppen, R	1
Hua, T	1
Hayward, A	1
Collins, J	1
Tamang, SM	1
Ishida, K	1
Miller, JB	1
Katz, S	1
Slocum, AH	1
Sulkowski, MS	1
Thomas, DL	1
Langer, R	1
Traverso, G	1
Kanyo, R	1
Wang, CK	1
Locskai, LF	1
Li, J	1
Allison, WT	1
Kurata, HT	1
Peng, K	1
Liu, H	1
Yan, B	1
Meng, XW	1
Song, SY	1
Ji, FH	1
Xia, Z	2
Biernacki, M	2
Baranowska-Kuczko, M	2
Niklińska, GN	1
Ma, CD	1
Imamura, M	1
Talley, DC	1
Rolt, A	1
Xu, X	1
Wang, AQ	1
Le, D	1
Uchida, T	1
Osawa, M	1
Teraoka, Y	1
Li, K	1
Hu, X	1
Park, SB	1
Chalasani, N	1
Irvin, PH	1
Dulcey, AE	1
Southall, N	1
Marugan, JJ	1
Hu, Z	1
Chayama, K	1
Frankowski, KJ	1
Liang, TJ	1
Batista, LA	3
Lopes, JB	1
Brianis, RC	1
Haibara, AS	2
Moreira, FA	6
Camarillo-López, RH	1
Hernández Rodríguez, M	1
Torres-Ramos, MA	1
Arciniega-Martínez, IM	1
García-Marín, ID	1
Correa Basurto, J	1
Méndez Méndez, JV	1
Rosales-Hernández, MC	1
Khakpai, F	1
Ren, J	2
Guo, J	1
Zhu, S	1
Wang, Q	1
Gao, R	1
Zhao, C	1
Feng, C	1
Qin, C	2
He, Z	1
Wang, Z	1
Zang, L	1
Zwierzyńska, E	1
Krupa-Burtnik, A	1
Pietrzak, B	1
Usama, SM	1
Inagaki, F	1
Kobayashi, H	1
Schnermann, MJ	1
Zhang, YM	1
Xu, HY	1
Hu, HN	1
Tian, FY	1
Chen, F	2
Liu, HN	1
Zhan, L	2
Pi, XP	1
Liu, J	3
Gao, ZB	1
Nan, FJ	1
Giovarelli, M	1
Zecchini, S	1
Catarinella, G	1
Moscheni, C	1
Sartori, P	1
Barbieri, C	1
Roux-Biejat, P	1
Napoli, A	1
Vantaggiato, C	1
Cervia, D	1
Perrotta, C	1
Clementi, E	1
Latella, L	1
De Palma, C	1
Licandro, SA	1
Crippa, L	1
Pomarico, R	1
Perego, R	1
Fossati, G	1
Leoni, F	1
Steinkühler, C	1
Grieco, M	1
De Caris, MG	1
Maggi, E	1
Armeli, F	1
Coccurello, R	1
Bisogno, T	1
D'Erme, M	1
Maccarrone, M	2
Mancini, P	1
Businaro, R	1
Weresa, J	3
Toczek, M	2
Kasacka, I	2
Harasim-Symbor, E	2
Malinowska, B	2
Dekkers, JS	1
Verheul, MK	1
Stoop, JN	2
Liu, B	1
Ioan-Facsinay, A	1
van Veelen, PA	1
de Ru, AH	1
Janssen, GMC	1
Hegen, M	2
Rapecki, S	1
Huizinga, TWJ	1
Trouw, LA	2
Toes, REM	1
Xiao, ZX	1
Chen, RQ	1
Hu, DX	1
Xie, XQ	1
Yu, SB	1
Chen, XQ	1
Liu, KJ	1
Kasper, G	1
Uhelski, ML	1
Gupta, K	1
Simone, DA	3
Wei, H	1
Zhou, T	1
Tan, B	1
Zhang, L	2
Li, M	2
Xiao, Z	1
Xu, F	1
Polak, A	1
Chabowski, A	1
Aisenberg, N	1
Serova, L	1
Shoshan, N	2
Segev, A	1
Abush, H	1
Seillier, A	1
Giuffrida, A	2
Mikheeva, IB	1
Shubina, L	1
Matveeva, N	1
Pavlik, LL	1
Kitchigina, VF	1
Tagami, S	1
Yanagida, K	1
Kodama, TS	1
Takami, M	1
Mizuta, N	1
Oyama, H	1
Nishitomi, K	1
Chiu, YW	1
Okamoto, T	1
Ikeuchi, T	1
Sakaguchi, G	1
Kudo, T	1
Matsuura, Y	1
Fukumori, A	1
Takeda, M	1
Ihara, Y	1
Okochi, M	1
Burchill, MA	1
Roby, JA	1
Crochet, N	1
Wind-Rotolo, M	1
Stone, AE	1
Edwards, MG	1
Dran, RJ	1
Kriss, MS	1
Gale, M	1
Rosen, HR	1
Sasso, O	2
Summa, M	1
Armirotti, A	2
Pontis, S	1
De Mei, C	1
Terrone, G	1
Pauletti, A	1
Salamone, A	1
Rizzi, M	1
Villa, BR	1
Porcu, L	1
Sheehan, MJ	1
Guilmette, E	1
Butler, CR	1
Piro, JR	1
Samad, TA	1
Vezzani, A	1
Morena, M	1
Berardi, A	1
Colucci, P	1
Palmery, M	1
Trezza, V	1
Hill, MN	2
Campolongo, P	1
Vanhoof-Villalba, SL	1
Gautier, NM	1
Mishra, V	1
Glasscock, E	1
Tóth, VE	1
Fehér, Á	1
Németh, J	1
Gyertyán, I	1
Zádori, ZS	1
Gyires, K	1
Choi, SH	1
Arai, AL	1
Mou, Y	1
Kang, B	1
Yen, CC	1
Hallenbeck, J	1
Silva, AC	1
Burstein, O	1
Doron, R	1
López-Hurtado, A	1
Burgos, DF	1
González, P	2
Dopazo, XM	2
González, V	1
Rábano, A	2
Mellström, B	2
Naranjo, JR	2
Risley, MG	1
Kelly, SP	1
Minnerly, J	1
Jia, K	1
Dawson-Scully, K	1
Jiang, HX	1
Ke, BW	1
Ma, G	1
Hai, KR	1
Gong, DY	1
Yang, Z	2
Zhou, C	1
Li, GB	1
Liu, JY	1
Feng, XM	1
Zhang, BL	1
Zhang, RS	1
Łuczaj, W	1
Jarocka-Karpowicz, I	1
Ambrożewicz, E	1
Friedrich, M	1
Gerbeth, L	1
Gerling, M	1
Rosenthal, R	1
Steiger, K	1
Weidinger, C	1
Keye, J	1
Schmidt, F	1
Weichert, W	1
Siegmund, B	1
Glauben, R	1
Hartmann, A	1
Fassini, A	2
Scopinho, A	1
Correa, FM	1
Guimarães, FS	2
Lisboa, SF	2
Resstel, LB	3
Aluja, D	1
Inserte, J	1
Penela, P	1
Ramos, P	1
Ribas, C	1
Iñiguez, MÁ	1
Mayor, F	1
Garcia-Dorado, D	1
Opdebeeck, B	1
Maudsley, S	1
Azmi, A	1
De Maré, A	1
De Leger, W	1
Meijers, B	1
Verhulst, A	1
Evenepoel, P	1
D'Haese, PC	1
Neven, E	1
Marshall, J	4
Nietupski, JB	3
Cao, J	1
Bangari, DS	3
Silvescu, C	1
Wilper, T	1
Randall, K	1
Tietz, D	1
Ying, X	1
Leonard, JP	3
Cheng, SH	4
Kralova, E	1
Racanska, E	1
Vicenova, A	1
Boselova, I	1
Malik, I	1
Stankovicova, T	1
Slusar, JE	1
Cairns, EA	1
Szczesniak, AM	1
Bradshaw, HB	1
Di Polo, A	1
Kelly, ME	2
Khasabova, IA	2
Holman, M	1
Morse, T	1
Burlakova, N	1
Coicou, L	1
Harding-Rose, C	2
Seybold, VS	2
Faure, JB	2
Akimana, G	2
Carneiro, JE	1
Cosquer, B	2
Ferrandon, A	2
Geiger, K	1
Koning, E	2
Penazzi, L	1
Cassel, JC	2
Nehlig, A	4
Tang, Q	1
Tan, L	1
Shen, Q	1
Huang, X	1
Wang, G	1
Chen, H	1
Nie, J	1
Li, S	2
Wu, L	1
Döring, G	1
Bragonzi, A	1
Paroni, M	1
Aktürk, FF	1
Cigana, C	1
Schmidt, A	1
Gilpin, D	1
Heyder, S	1
Born, T	1
Smaczny, C	1
Kohlhäufl, M	1
Wagner, TO	1
Loebinger, MR	1
Bilton, D	1
Tunney, MM	1
Elborn, JS	1
Pier, GB	1
Konstan, MW	1
Ulrich, M	1
Azuma, M	2
Hammond, KB	1
Nakajima, E	2
Shearer, TR	2
Pietrement, C	1
Gorisse, L	1
Jaisson, S	1
Gillery, P	1
Bitencourt, CS	1
Bessi, VL	1
Huynh, DN	1
Ménard, L	1
Lefebvre, JS	1
Lévesque, T	1
Hamdan, L	1
Sohouhenou, F	1
Faccioli, LH	1
Borgeat, P	1
Marleau, S	1
Anderson, WB	1
Gould, MJ	1
Torres, RD	1
Mitchell, VA	3
Vaughan, CW	3
Hayashi, H	1
Iwata, M	1
Tsuchimori, N	1
Matsumoto, T	1
Hatch, RJ	1
Reid, CA	1
Petrou, S	1
Marques-Carneiro, JE	1
Herbeaux, K	1
Barbelivien, A	1
Allen, SJ	1
Mott, KR	1
Ghiasi, H	1
Pulgar, VM	1
Yamaleyeva, LM	1
Varagic, J	1
McGee, CM	1
Bader, M	1
Dechend, R	1
Howlett, AC	1
Brosnihan, KB	1
Meng, WQ	1
Lu, L	1
Xue, YS	1
Li, C	1
Zou, F	1
Liu, Y	1
Zhao, J	1
Parker, LA	3
Downey, R	1
Limebeer, CL	3
Rock, EM	3
Sticht, MA	1
Morris, H	1
Abdullah, RA	2
Lichtman, AH	3
Lomazzo, E	1
Bindila, L	1
Remmers, F	1
Lerner, R	1
Schwitter, C	1
Hoheisel, U	1
Lutz, B	3
Bedse, G	2
Colangeli, R	1
Lavecchia, AM	1
Romano, A	2
Altieri, F	1
Cifani, C	2
Cassano, T	2
Gaetani, S	2
Katz, PS	1
Sulzer, JK	1
Impastato, RA	1
Teng, SX	1
Rogers, EK	1
Molina, PE	1
Gilet, M	1
Eutamene, H	1
Han, H	1
Kim, HW	1
Bueno, L	1
Zhou, P	1
Xu, H	1
Chen, X	1
Li, X	1
Pi, X	1
Nan, F	1
Gao, Z	1
Viana, TG	1
Hott, SC	1
Aguiar, DC	1
Krause, M	1
Keller, J	1
Beil, B	1
van Driel, I	1
Zustin, J	1
Barvencik, F	1
Schinke, T	1
Amling, M	1
Shekh-Ahmad, T	1
Mawasi, H	1
McDonough, JH	1
Finnell, RH	1
Wlodarczyk, BJ	1
Yavin, E	1
Bialer, M	1
Nasirinezhad, F	1
Jergova, S	1
Pearson, JP	2
Sagen, J	1
Chauvet, C	1
Nicolas, C	1
Thiriet, N	1
Lardeux, MV	1
Duranti, A	3
Solinas, M	1
Aguilar, DD	2
Chen, L	1
Lodge, DJ	2
Griebel, G	1
Pichat, P	1
Beeské, S	1
Leroy, T	1
Redon, N	1
Jacquet, A	1
Françon, D	1
Bert, L	1
Even, L	1
Lopez-Grancha, M	1
Tolstykh, T	1
Sun, F	1
Yu, Q	1
Brittain, S	1
Arlt, H	1
He, T	1
Zhang, B	2
Wiederschain, D	1
Bertrand, T	1
Houtmann, J	1
Rak, A	1
Vallée, F	1
Michot, N	1
Augé, F	1
Menet, V	1
Bergis, OE	1
George, P	1
Avenet, P	1
Mikol, V	1
Didier, M	1
Escoubet, J	1
Tempesta, B	1
Lavecchia, MA	1
Pace, L	1
Bellomo, A	1
Micioni Di Bonaventura, MV	1
Cai, J	1
Fang, D	1
Liu, XD	1
Xing, GG	1
Borges, AA	1
Nejo, P	1
Bastos, JR	1
Fischer, A	1
Hayer, S	1
Huizinga, TW	1
Steiner, G	1
Toes, RE	1
Cerina, M	1
Szkudlarek, HJ	1
Coulon, P	1
Meuth, P	1
Kanyshkova, T	1
Nguyen, XV	1
Göbel, K	1
Seidenbecher, T	1
Meuth, SG	1
Pape, HC	1
Budde, T	1
Malek, N	1
Mrugala, M	1
Makuch, W	1
Kolosowska, N	1
Przewlocka, B	1
Binkowski, M	1
Czaja, M	1
Morera, E	1
Di Marzo, V	1
Starowicz, K	1
Mangubat, EZ	1
Kellogg, RG	1
Harris, TJ	1
Rossi, MA	1
Yu, F	1
Nozaki, C	1
Markert, A	1
Zimmer, A	1
Li, F	1
Xu, D	1
Shu, N	1
Zhong, Z	1
Zhang, M	1
Liu, C	1
Ling, Z	1
Liu, L	1
Liu, X	1
Sheppard, AM	1
Chen, GD	1
Salvi, R	1
Ashe, KM	1
Budman, E	2
Siegel, CS	1
Desnick, RJ	1
Scheule, RK	1
Qin, M	1
Zeidler, Z	1
Moulton, K	1
Krych, L	1
Smith, CB	1
Wang, F	1
Wang, X	1
Sun, R	1
Chen, J	1
Chen, B	1
Kalappa, BI	1
Soh, H	1
Duignan, KM	1
Furuya, T	1
Edwards, S	1
Tzingounis, AV	1
Tzounopoulos, T	1
Abd-Elsayed, AA	1
Ikeda, R	1
Jia, Z	1
Ling, J	1
Zuo, X	1
Gu, JG	1
Carnevali, L	2
Vacondio, F	2
Rossi, S	3
Callegari, S	1
Macchi, E	2
Spadoni, G	2
Bedini, A	2
Rivara, S	2
Mor, M	3
Sgoifo, A	2
Adamson Barnes, NS	1
Kazantzis, NP	1
Wills, KL	1
Petrie, GN	1
Millett, G	1
Neumann, ID	1
Villar, D	1
Morón-Oset, J	1
Higueras, E	1
Oliveros, JC	1
Arrabal, MD	1
Prieto, A	1
Cercós, P	1
González, T	1
De la Cruz, A	1
Casado-Vela, J	1
Valenzuela, C	1
Gutierrez-Rodriguez, M	1
Li, JY	1
Wilkerson, JL	1
Grim, TW	1
Mustafa, MA	1
Poklis, JL	1
Dewey, WL	1
Akbarali, H	1
Banks, ML	1
Wise, LE	1
Zer-Aviv, TM	1
Sun, Y	2
Allaire, A	1
Cromwell, MA	1
Grabowski, GA	1
Bernal, L	1
Lopez-Garcia, JA	1
Roza, C	1
Yesilyurt, O	1
Cayirli, M	1
Sakin, YS	1
Seyrek, M	1
Akar, A	1
Dogrul, A	1
Rubenstein, R	1
Wang, KK	1
Chiu, A	1
Grinkina, N	1
Sharma, DR	1
Agarwal, S	1
Lin, F	1
Friedman, AK	1
Juarez, B	1
Ku, SM	1
Calizo, RC	1
Walsh, JJ	1
Chaudhury, D	1
Zhang, S	1
Hawkins, A	1
Dietz, DM	1
Murrough, JW	1
Ribadeneira, M	1
Wong, EH	1
Neve, RL	1
Han, MH	1
Ohman, KA	1
Hashim, YM	1
Vangveravong, S	1
Nywening, TM	1
Cullinan, DR	1
Goedegebuure, SP	1
Van Tine, BA	1
Tiriac, H	1
Tuveson, DA	1
DeNardo, DG	1
Spitzer, D	1
Mach, RH	1
Hawkins, WG	1
Celorrio, M	1
Fernández-Suárez, D	1
Rojo-Bustamante, E	1
Echeverry-Alzate, V	1
Ramírez, MJ	1
Hillard, CJ	1
López-Moreno, JA	1
Maldonado, R	1
Oyarzábal, J	1
Franco, R	1
Aymerich, MS	1
Schenberg, LC	1
Wang, D	1
Su, S	1
Liu, K	1
Wu, Y	1
Wu, Z	1
Li, L	1
Xie, F	1
Du, J	1
Zuo, Y	1
Frost, JA	1
Carlton, SM	1
Walters, ET	1
Yang, Q	1
Viveros-Paredes, JM	1
Gonzalez-Castañeda, RE	1
Escalante-Castañeda, A	1
Tejeda-Martínez, AR	1
Castañeda-Achutiguí, F	1
Flores-Soto, ME	1
Treleaven, CM	1
Olszewski, MA	1
Dodge, JC	1
Makino, E	1
Sidman, RL	1
Jhaveri, MD	2
Richardson, D	2
Robinson, I	1
Garle, MJ	1
Patel, A	2
Sagar, DR	2
Bennett, AJ	2
Alexander, SP	2
Kendall, DA	4
Barrett, DA	3
Chapman, V	4
Hasanein, P	1
Shahidi, S	1
Komaki, A	1
Mirazi, N	1
Luszczki, JJ	1
Wu, JZ	1
Raszewski, G	1
Czuczwar, SJ	1
Feuerbach, D	1
Lingenhoehl, K	1
Olpe, HR	1
Vassout, A	1
Gentsch, C	1
Chaperon, F	1
Nozulak, J	1
Enz, A	1
Bilbe, G	1
McAllister, K	1
Hoyer, D	1
Koumura, A	1
Nonaka, Y	1
Hyakkoku, K	1
Oka, T	2
Shimazawa, M	1
Hozumi, I	1
Inuzuka, T	1
Hara, H	1
Ballatore, C	1
Trojanowski, JQ	1
Lee, VM	1
Smith, AB	1
Redrobe, JP	1
Nielsen, AN	1
Hlawaty, H	1
Jacob, MP	1
Louedec, L	1
Letourneur, D	1
Brink, C	1
Michel, JB	1
Feldman, L	1
Bäck, M	1
Haller, J	1
Barna, I	1
Barsvari, B	1
Gyimesi Pelczer, K	1
Yasar, S	1
Panlilio, LV	1
Goldberg, S	1
Rezvani, AH	2
Overstreet, DH	2
Vaidya, AH	1
Zhao, B	1
Levin, ED	2
Dencker, D	2
Husum, H	2
Choi, H	1
Lee, J	1
Kim, YH	1
Im, DS	1
Hwang, IC	1
Kim, SJ	1
Moon, SK	1
Lee, HW	1
Lee, SS	1
Ahn, SK	1
Kim, SW	1
Choi, NS	1
Lee, KJ	1
Perucca, E	1
Yoshikawa, Y	2
Zhang, GX	2
Obata, K	2
Ohga, Y	1
Matsuyoshi, H	1
Taniguchi, S	2
Takaki, M	2
Waring, JF	1
Ciurlionis, R	1
Marsh, K	1
Klein, LL	1
Degoey, DA	1
Randolph, JT	1
Spear, B	1
Kempf, DJ	1
Burashnikov, A	1
Zygmunt, AC	1
Di Diego, JM	1
Linhardt, G	1
Carlsson, L	1
Antzelevitch, C	1
Sankar, R	3
Auvin, S	1
Kwon, YS	2
Pineda, E	1
Shin, D	2
Mazarati, A	2
Swaney, JS	1
Chapman, C	1
Correa, LD	1
Stebbins, KJ	1
Bundey, RA	1
Prodanovich, PC	1
Fagan, P	1
Baccei, CS	1
Santini, AM	1
Hutchinson, JH	1
Seiders, TJ	1
Parr, TA	1
Prasit, P	1
Evans, JF	1
Lorrain, DS	1
Lu, X	1
Roberts, E	1
Xia, F	1
Sanchez-Alavez, M	1
Liu, T	1
Baldwin, R	1
Wu, S	1
Chang, J	1
Wasterlain, CG	1
Bartfai, T	1
Huang, HS	1
Buck, CB	1
Lambert, PF	1
Jain, S	1
Saraf, S	1
Kelly, RF	1
Lamont, KT	1
Somers, S	1
Hacking, D	1
Lacerda, L	1
Thomas, P	1
Opie, LH	1
Lecour, S	1
Johnston, TH	1
Huot, P	1
Fox, SH	1
Wakefield, JD	1
Sykes, KA	1
Bartolini, WP	1
Milne, GT	1
Brotchie, JM	1
Lu, Z	1
Napolitano, JB	1
Theberge, A	1
Ali, A	1
Hammond, ML	1
Tan, E	1
Tong, X	1
Xu, SS	1
Latham, MJ	1
Peterson, LB	1
Anderson, MS	1
Eveland, SS	1
Guo, Q	1
Hyland, SA	1
Milot, DP	1
Chen, Y	1
Sparrow, CP	1
Wright, SD	1
Sinclair, PJ	1
Schuelert, N	1
Johnson, MP	1
Oskins, JL	1
Jassal, K	1
Chambers, MG	1
McDougall, JJ	1
Umathe, SN	1
Manna, SS	1
Jain, NS	1
Wendt, H	1
Soerensen, J	1
Wotjak, CT	1
Potschka, H	1
Bousquet, E	1
Camelo, S	1
Leroux les Jardins, G	1
Goldenberg, B	1
Naud, MC	1
Besson-Lescure, B	1
Lebreton, L	1
Annat, J	1
Behar-Cohen, F	1
de Kozak, Y	1
Chakraborty, R	1
Vepuri, V	1
Mhatre, SD	1
Paddock, BE	1
Miller, S	1
Michelson, SJ	1
Delvadia, R	1
Desai, A	1
Vinokur, M	1
Melicharek, DJ	1
Utreja, S	1
Khandelwal, P	1
Ansaloni, S	1
Goldstein, LE	1
Moir, RD	1
Lee, JC	1
Tabb, LP	1
Saunders, AJ	1
Marenda, DR	1
Ono, T	1
Moshé, SL	1
Galanopoulou, AS	1
Naderi, N	1
Ahmad-Molaei, L	1
Mazar-Atabaki, A	1
Ronaghi, A	1
Shirazi-zand, Z	1
Motiei-Langroudi, SM	1
Eslahkar, S	1
Nodera, H	1
Spieker, A	1
Sung, M	1
Rutkove, S	1
Ryu, M	1
Yasuda, M	1
Shi, D	1
Shanab, AY	1
Watanabe, R	1
Himori, N	1
Omodaka, K	1
Yokoyama, Y	1
Takano, J	1
Saido, T	1
Nakazawa, T	1
Johnson, DM	1
de Jong, MM	1
Crijns, HJ	1
Carlsson, LG	1
Volders, PG	1
Large, CH	1
Sokal, DM	1
Gunthorpe, MJ	1
Crean, CS	1
Vanlandingham, KE	1
White, HS	2
Bertorelli, R	1
Bandiera, T	1
Scarpelli, R	1
Colombano, G	1
Moreno-Sanz, G	1
Hamtiaux, L	1
Masquelier, J	1
Muccioli, GG	1
Bouzin, C	1
Feron, O	1
Gallez, B	1
Lambert, DM	1
Odan, M	1
Ishizuka, N	1
Hiramatsu, Y	1
Inagaki, M	1
Hashizume, H	1
Fujii, Y	1
Mitsumori, S	1
Morioka, Y	1
Soga, M	1
Deguchi, M	1
Yasui, K	1
Arimura, A	1
Rheims, S	1
Ryvlin, P	1
Lawrence, AJ	1
Arolfo, MP	1
Khasabov, S	1
Paz, J	1
Okine, BN	1
Norris, LM	1
Woodhams, S	1
Burston, J	1
Psychoyos, D	1
Hungund, BL	1
Tejani-Butt, SM	1
John, CS	1
Currie, PJ	1
Zaitone, SA	1
El-Wakeil, AF	1
Abou-El-Ela, SH	1
Khatri, M	1
Rai, SK	1
Ranbhor, R	1
Kishore, K	1
Tiwari, M	1
Butti, E	1
Bacigaluppi, M	1
Cambiaghi, M	1
Bari, M	1
Cebrian Silla, A	1
Brambilla, E	1
Musella, A	1
De Ceglia, R	1
Teneud, L	1
De Chiara, V	1
D'Adamo, P	1
Garcia-Verdugo, JM	1
Comi, G	1
Muzio, L	1
Quattrini, A	1
Leocani, L	1
Centonze, D	1
Martino, G	1
Mani, BK	1
O'Dowd, J	1
Kumar, L	1
Brueggemann, LI	1
Ross, M	1
Byron, KL	1
Tchantchou, F	1
Lenglet, S	1
Thomas, A	1
Soehnlein, O	1
Montecucco, F	1
Burger, F	1
Pelli, G	1
Galan, K	1
Cravatt, B	1
Staub, C	1
Steffens, S	1
Takeshita, D	1
Mitsuyama, S	1
Ito, H	1
Vilela, LR	1
Medeiros, DC	1
Rezende, GH	1
de Oliveira, AC	1
Moraes, MF	1
Kianian, M	1
Al-Banna, NA	1
Lehmann, C	1
Ballmaier, M	1
Casamenti, F	1
Scali, C	1
Mazzoncini, R	1
Zoli, M	1
Pepeu, G	1
Spano, PF	1
Blackburn-Munro, G	1
Jensen, BS	1
Passmore, GM	1
Selyanko, AA	1
Mistry, M	1
Al-Qatari, M	1
Marsh, SJ	1
Matthews, EA	1
Dickenson, AH	1
Brown, TA	1
Burbidge, SA	1
Main, M	1
Brown, DA	1
Dost, R	1
Rostock, A	1
Rundfeldt, C	3
el-Batran, SA	1
el-Shenawy, SM	1
Nofal, SM	1
Abdel-Salam, OM	1
Arbid, MS	1
Mani, S	1
Macapinlac, M	1
Goel, S	1
Verdier-Pinard, D	1
Fojo, T	1
Rothenberg, M	1
Colevas, D	1
Otto, JF	1
Frankel, WN	1
Wilcox, KS	1
Ordaz-Pichardo, C	1
Shibayama, M	1
Villa-Treviño, S	1
Arriaga-Alba, M	1
Angeles, E	1
de la Garza, M	1
Smith, DT	2
Shi, R	2
Borgens, RB	2
McBride, JM	2
Jackson, K	1
Byrn, SR	2
Holt, S	1
Comelli, F	1
Costa, B	1
Fowler, CJ	1
Kodvawala, A	1
Ghering, AB	1
Davidson, WS	1
Hui, DY	1
Jayamanne, A	1
Greenwood, R	1
Aslan, S	1
Kneteman, NM	1
Weiner, AJ	2
O'Connell, J	1
Collett, M	1
Gao, T	1
Aukerman, L	1
Kovelsky, R	1
Ni, ZJ	1
Zhu, Q	2
Hashash, A	1
Kline, J	1
Hsi, B	1
Schiller, D	1
Douglas, D	1
Tyrrell, DL	1
Mercer, DF	1
Walkup, RD	1
Tamada, Y	1
Tochigi, A	1
Lotti, M	1
Moretto, A	1
Oei, Y	1
Mendel, DB	1
Garrett, EN	1
Patawaran, MB	1
Hollenbach, PW	1
Aukerman, SL	1
Richter, A	1
Sander, SE	1
Iskit, AB	1
Erkent, U	1
Ertunc, M	1
Guc, MO	1
Ilhan, M	1
Onur, R	1
Naidu, PS	1
Varvel, SA	1
Ahn, K	1
Martin, BR	1
Kreitzer, AC	1
Malenka, RC	1
Miura, Y	1
Rahmathullah, SM	1
Tidwell, RR	1
Jones, SK	1
Hall, JE	1
Boykin, DW	1
Bortolato, M	1
Mangieri, RA	1
Fu, J	1
Kim, JH	1
Arguello, O	1
Tontini, A	1
Tarzia, G	1
Qiu, C	1
Johnson, BN	1
Tallent, MK	1
Kaiser, N	1
Monory, K	1
McLaughlin, RJ	1
Morrish, AC	1
Gorzalka, BB	1
François, J	1
Boehrer, A	1
Degn, M	1
Lambertsen, KL	1
Petersen, G	1
Meldgaard, M	1
Artmann, A	1
Clausen, BH	1
Hansen, SH	1
Finsen, B	1
Hansen, HS	1
Lund, TM	1
Kulig, K	1
Malawska, B	1
Grauer, E	1
Levy, A	1
Mechoulam, R	1
Dias, R	1
Pedersen, ML	1
Storr, MA	1
Keenan, CM	1
Emmerdinger, D	1
Yüce, B	1
Sibaev, A	1
Massa, F	1
Buckley, NE	1
Göke, B	1
Brand, S	1
Patel, KD	1
Sharkey, KA	1
Grabenstatter, HL	1
Dudek, FE	1
Wu, J	1
O'Brien, PM	1
Sliskovic, DR	1
Blankley, CJ	1
Roth, BD	1
Wilson, MW	1
Hamelehle, KL	1
Krause, BR	1
Stanfield, RL	1
Ballaz, S	1
Barber, A	1
Fortuño, A	1
Del Río, J	1
Martin-Martínez, M	1
Gómez-Monterrey, I	1
Herranz, R	1
González-Muñiz, R	1
García-López, MT	1
Oz, HS	1
Hughes, WT	1
Rehg, JE	1
Wright, CD	1
Havill, AM	1
Middleton, SC	1
Kashem, MA	1
Dripps, DJ	1
Abraham, WM	1
Thomson, DS	1
Burgess, LE	1
Armand, V	1
Heinemann, U	1
Gonzalez, MI	1
Field, MJ	1
Hughes, J	1
Singh, L	1
Fisher, A	1
Yokota, Y	1
Peyman, A	1
Scheunemann, K	1
Will, DW	1
Knolle, J	1
Wehner, V	1
Breipohl, G	1
Stilz, HU	1
Carniato, D	1
Ruxer, J	1
Gourvest, J	1
Auberval, M	1
Doucet, B	1
Baron, R	1
Gaillard, M	1
Gadek, TR	1
Bodary, S	1
Sun, X	2
Zeckner, DJ	1
Current, WL	2
Boyer, R	1
McMillian, C	1
Yumibe, N	1
Chen, SH	2
Zeckner, D	1
Sachs, RK	1
Rodriguez, M	1
Lagrue, G	1
Hirbec, G	1
Moisy, M	1
Sternberg, M	1
Blanc, C	1
Stone, PJ	1
Lucey, EC	1
Noskova, D	1
Digenis, GA	1
Snider, GL	1
Biel-Zielińska, A	1
Brzeziński, J	1
D'Mello, GD	1
Sidell, FR	1
Aĭvazian, LK	1
Sheu, CW	1
Lee, JK	1
Arras, CA	1
Jones, RL	1
Lavappa, KS	1
Hershman, MJ	1
Trachtenberg, LS	1
Pietsch, JD	1
Mooney, TH	1
DeWeese, RC	1
Cheadle, WG	1
Hochwalt, AE	1
Wirgin, I	1
Felber, M	1
Currie, DD	1
Garte, SJ	1
Zinnes, H	1
Lindo, NA	1
Sircar, JC	1
Schwartz, ML	1
Shavel, J	1
DiPasquale, G	1
Olefir, AI	1
Smith, GR	1
O-Ishi, S	1
Sakuma, A	1
Lämmler, G	1
Srivastava, VK	1
Zahner, H	1
Blickens, DA	1
Riggi, SJ	1